Evofem Biosciences Inc (EVFM):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Evofem Biosciences Inc (EVFM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8068
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Evofem Biosciences Inc (Evofem) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes reproductive and contraceptive care products for women. The company’s lead product candidate includes Amphora, a non-hormonal vaginal contraceptive gel for the prevention of urogenital chlamydia and gonorrhea in women. Evofem uses proprietary multi-purpose prevention technology vaginal gel to develop product candidates for multiple indications, including contraception; prevention of urogenital transmission of chlamydia and gonorrhea in women, and recurrent bacterial vaginosis. The company concentrates on women’s sexual health and reproductive care, contraception, and the prevention of sexually transmitted infections. Evofem is headquartered in San Diego, California, the US.

Evofem Biosciences Inc (EVFM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Evofem Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Evofem Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Evofem Biosciences Raises USD7.5 Million Venture Financing 11
Evofem Holdings Raises USD20.5 Million in Venture Financing 12
Evofem Raises USD20 Million in Financing Round 13
Partnerships 14
Evofem Enters into Agreement with DKT International 14
Merger 15
Neothetics and Evofem Biosciences Merges 15
Equity Offering 17
Evofem Biosciences Raises USD39.9 Million in Public Offering of Shares 17
Evofem Biosciences Files Registration Statement to Raise up to USD57.5 Million in Public Offering of Shares 19
Evofem Biosciences Files Registration Statement to Raise up to USD122.3 Million in Public Offering of Shares 20
Evofem Raises USD25 Million in Private Placement of Shares 21
Evofem Biosciences Inc – Key Competitors 22
Evofem Biosciences Inc – Key Employees 23
Evofem Biosciences Inc – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Product News 25
05/11/2017: Neothetics Provides Business Update on Lead Product Candidate LIPO-202 25
Clinical Trials 26
Jun 26, 2017: Neothetics Announces Top-Line Results for Phase 2 Proof-of-Concept Study of LIPO-202 for the Reduction of Submental Subcutaneous Fat 26
Mar 20, 2017: Neothetics Announces Last Subject Enrolled in Phase 2 Proof of Concept Trial for LIPO-202 for the Reduction of Submental Subcutaneous Fat 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Evofem Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Evofem Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Evofem Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Evofem Biosciences Raises USD7.5 Million Venture Financing 11
Evofem Holdings Raises USD20.5 Million in Venture Financing 12
Evofem Raises USD20 Million in Financing Round 13
Evofem Enters into Agreement with DKT International 14
Neothetics and Evofem Biosciences Merges 15
Evofem Biosciences Raises USD39.9 Million in Public Offering of Shares 17
Evofem Biosciences Files Registration Statement to Raise up to USD57.5 Million in Public Offering of Shares 19
Evofem Biosciences Files Registration Statement to Raise up to USD122.3 Million in Public Offering of Shares 20
Evofem Raises USD25 Million in Private Placement of Shares 21
Evofem Biosciences Inc, Key Competitors 22
Evofem Biosciences Inc, Key Employees 23

List of Figures
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Evofem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Evofem Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Evofem Biosciences Inc (EVFM):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ContraFect Corp (CFRX):企業の財務・戦略的SWOT分析
    Summary ContraFect Corp (ContraFect) operates as a clinical stage biotechnology company that discovers and develops therapeutic protein and antibody products. The company develops products using lysin and monoclonal antibody platforms for the treatment of life threatening, drug-resistant infectious …
  • Petrol dd Ljubljana (PETG):石油・ガス:M&Aディール及び事業提携情報
    Summary Petrol dd Ljubljana (Petrol dd) is an energy company. It markets and distributes oil and petroleum products, electricity, heat, merchandise, natural gas and liquefied petroleum gas (LPG). The company sells automotive products, foodstuffs, accessories, tobacco, and chemical products. Petrol d …
  • The Co-operative Bank Plc:企業の戦略・SWOT・財務情報
    The Co-operative Bank Plc - Strategy, SWOT and Corporate Finance Report Summary The Co-operative Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Asbury Automotive Group, Inc.:企業の戦略・SWOT・財務情報
    Asbury Automotive Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Asbury Automotive Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Anteo Diagnostics Ltd (ADO):企業の財務・戦略的SWOT分析
    Anteo Diagnostics Ltd (ADO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Monster Worldwide Inc:企業の戦略的SWOT分析
    Monster Worldwide Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Al Rajhi Banking & Investment Corporation (1120):企業の財務・戦略的SWOT分析
    Al Rajhi Banking & Investment Corporation (1120) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Correvio Pharma Corp (CORV):企業の財務・戦略的SWOT分析
    Correvio Pharma Corp (CORV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • The Dai-ichi Life Insurance Co Ltd:戦略・SWOT・企業財務分析
    The Dai-ichi Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The Dai-ichi Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • AptarGroup Inc:企業の戦略・SWOT・財務情報
    AptarGroup Inc - Strategy, SWOT and Corporate Finance Report Summary AptarGroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Nuverra Environmental Solutions, Inc. (NES)-石油・ガス分野:企業M&A・提携分析
    Summary Nuverra Environmental Solutions, Inc. (Nuverra), formerly known as Heckmann Corporation, provides environmental solutions to customers focused on the development and ongoing production of oil and natural gas from shale formations. It provides environmental solutions, including delivery, coll …
  • Werner Enterprises, Inc.:企業の戦略・SWOT・財務分析
    Werner Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Werner Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Challenge Group Holdings PTE. LTD.:企業の戦略・SWOT・財務情報
    Challenge Group Holdings PTE. LTD. - Strategy, SWOT and Corporate Finance Report Summary Challenge Group Holdings PTE. LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • The Walt Disney Company:企業の戦略・SWOT・財務分析
    The Walt Disney Company - Strategy, SWOT and Corporate Finance Report Summary The Walt Disney Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Etrion Corp (ETX):企業の財務・戦略的SWOT分析
    Summary Etrion Corp (Etrion) formerly PetroFalcon Corp, is a solar energy development company. The company produce power and builds, owns and operates utility-scale solar power generation plants. It develops greenfield solar power projects in Japan and Chile. Etrion owns and operates 56.7 MW of sola …
  • Luye Pharma Group Co Ltd (2186):製薬・医療:M&Aディール及び事業提携情報
    Summary Luye Pharma Group Co Ltd (Luye Pharma) is a pharmaceutical company that develops, produces and markets pharmaceutical products in the therapeutic areas of oncology, cardiovascular, metabolism and central nervous system. The company’s products include sodium aescinate for injection, xuezhikan …
  • UGI Corp (UGI):石油・ガス:M&Aディール及び事業提携情報
    Summary UGI Corp (UGI) is a holding company providing energy products and services. Through subsidiaries, the company stores, transports, distributes and markets energy products and related services. It distributes propane and butane both domestically and internationally and provides natural gas and …
  • Advanced Biological Laboratories SA-製薬・医療分野:企業M&A・提携分析
    Summary Advanced Biological Laboratories SA (ABL) is a healthcare information technology company that provides integrated software solutions for personalised medicine. The company’s products include improving disease management software, project management software, cumulative reporting and related …
  • Coal India Ltd:戦略・SWOT・企業財務分析
    Coal India Ltd - Strategy, SWOT and Corporate Finance Report Summary Coal India Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Intuit Inc.:企業の戦略・SWOT・財務情報
    Intuit Inc. - Strategy, SWOT and Corporate Finance Report Summary Intuit Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆